188 related articles for article (PubMed ID: 35473543)
1. Unravelling Micro and Nano vesicular System in Intranasal Drug Delivery for Epilepsy.
Salave S; Rana D; Pardhe R; Bule P; Benival D
Pharm Nanotechnol; 2022 Apr; ():. PubMed ID: 35473543
[TBL] [Abstract][Full Text] [Related]
2. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
[TBL] [Abstract][Full Text] [Related]
3. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
[TBL] [Abstract][Full Text] [Related]
5. A review of intranasal formulations for the treatment of seizure emergencies.
Kapoor M; Cloyd JC; Siegel RA
J Control Release; 2016 Sep; 237():147-59. PubMed ID: 27397490
[TBL] [Abstract][Full Text] [Related]
6. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery.
Shringarpure M; Gharat S; Momin M; Omri A
Expert Opin Drug Deliv; 2021 Feb; 18(2):169-185. PubMed ID: 32921169
[TBL] [Abstract][Full Text] [Related]
7. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis.
Costa C; Moreira JN; Amaral MH; Sousa Lobo JM; Silva AC
J Control Release; 2019 Feb; 295():187-200. PubMed ID: 30610952
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnological advances in the treatment of epilepsy: a comprehensive review.
Rai G; Sharma S; Bhasin J; Aggarwal K; Ahuja A; Dang S
Nanotechnology; 2024 Jan; 35(15):. PubMed ID: 38194705
[TBL] [Abstract][Full Text] [Related]
9. Potential of nanoparticulate drug delivery systems by intranasal administration.
Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
Hu X; Yue X; Wu C; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive Gel-loaded Oxcarbazepine Nanosystems for Nose- To-Brain Delivery: Enhanced Antiepileptic Activity in Rats.
Abou-Taleb BA; El-Ganainy SO
Pharm Res; 2023 Jul; 40(7):1835-1852. PubMed ID: 37353628
[TBL] [Abstract][Full Text] [Related]
12. Nasal delivery of neurotherapeutics
Rajput A; Pingale P; Dhapte-Pawar V
Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
[TBL] [Abstract][Full Text] [Related]
13. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Keller LA; Merkel O; Popp A
Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.
Bahadur S; Sachan N; Harwansh RK; Deshmukh R
Curr Pharm Des; 2020; 26(12):1331-1344. PubMed ID: 32160843
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
Alshweiat A; Ambrus R; Csoka I
Curr Med Chem; 2019; 26(35):6459-6492. PubMed ID: 31453778
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of drug delivery to the brain via nasal route.
Kozlovskaya L; Abou-Kaoud M; Stepensky D
J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
